Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

VEC.L (VEC) Share News

567891011121314

Vectura Receives Bulgarian Marketing Authorisation For Inhaler

4th Feb 2014 16:43

LONDON (Alliance News) - Vectura Group PLC Tuesday said partner Sandoz has received marketing authorisation from Bulgarian authorities for its new inhaler for patients with respiratory problems. The product, known as AirFluSal Forspiro, is an inhaler for patients with asthma and chronic obs Read More

Vectura Partner Gets Romanian Approval For Asthma Inhaler

29th Jan 2014 14:15

LONDON (Alliance News) - Vectura Group PLC said Wednesday that its partner Sandoz has received marketing approval for its AirFluSal Forspiro asthma inhaler in Romania. Vectura will receive a EUR1.5 million milestone payment as a result of the marketing authorisation. The product has alread Read More

Vectura Partner Sandoz Launches AirFluSal Asthma Inhaler In Denmark

20th Jan 2014 13:36

LONDON (Alliance News) - Vectura Group PLC said Monday that its partner Sandoz has launched its AirFluSal Forspiro asthma inhaler in Denmark. AirFluSal Forspiro received EU market authorisation in Denmark December 18 2013. Sandoz is the generics division of Swiss pharmaceutical compan Read More

Vectura Partner Sandoz Gets Hungarian Approval For Asthma Inhaler

16th Jan 2014 13:26

LONDON (Alliance News) - Vectura Group PLC said Thursday that its partner Sandoz, part of Novartis AG, has received marketing authorisation for its AirFluSal Forspira inhaler in Hungary. The authorisation comes after AirFluSal Forspira received marketing authorisation in Germany on Monday, Read More

Vectura Partner Sandoz Receives Swedish Okay For Asthma Inhaler

14th Jan 2014 12:36

LONDON (Alliance News) - Vectura Group PLC said Tuesday that its partner Sandoz has received marketing authorisation for its AirFluSal Forspira inhaler in Sweden. The authorisation comes just a day after AirFluSal Forspira received marketing authorisation in Germany. The AirFluSal inh Read More

UK BROKER RATING CHANGES: Barclays Initiates Housebuilders

20th Nov 2013 10:14

Read More

Vectura Widens Pretax Loss On Increased Research And Development Expenses

19th Nov 2013 13:11

Read More

Vectura, UCB To Collaborate To Develop Biologic Immunomodulatory Product

30th Sep 2013 06:24

Read More

Broker Rating Changes Summary - Numis, Panmure Call Vectura A Buy

23rd Sep 2013 11:04

Read More

Vectura Gains European Approval For Once-Daily Dual Bronchodilator

23rd Sep 2013 10:31

Read More

Vectura Chairman To Retire After 12 Years At Helm

23rd Sep 2013 06:39

Read More

Broker Rating Changes Summary - SocGen Raises GKN To Buy

20th Sep 2013 10:42

Read More

567891011121314
FTSE 100 Latest
Value8,809.74
Change53.53